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Summary
Background: Oxytocin is known to enhance recognition of emotional expressions and may
increase attention to the eye region. Therefore, we investigated whether oxytocin administration
would lead to increased orienting of attention in response to gaze cues of emotional faces.
Methods: In a randomized placebo-controlled double-blind crossover study 20 healthy males
received 24 IU of oxytocin or placebo. Thirty-five minutes after administration they performed a
gaze cueing task with happy, fearful and neutral faces. Stress levels were measured throughout
the study.
Results: Oxytocin did not affect stress levels during the study, but significantly increased gaze
cueing scores for happy and fearful expressions compared to placebo. No effects were found for
neutral expressions. Trait anxiety or depression did not moderate the effect.
Conclusions: Oxytocin increases orienting of attention in response to emotional gaze cues, both
for happy and fearful expressions. Replication is needed in female and clinical populations.
Effects of oxytocin on early, automatic processing levels should be studied in relation to
previously found pro-social and behavioral effects of oxytocin.
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Oxytocin affects many social and emotion-related behaviors
including trust, attachment behavior, responding to stress,
social memory, and the ability to recognize and discernd.
1 Recent analyses of the nasal sprays that were used for this
experiment (Blockland DRUM03211) by the academic pharmacy
revealed that there is inter- and intra-individual variance in the
amount of IU that is delivered per puff, with an average of 2.5 IU per
puff (i.e. 15 IUs in total).
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et al., 2011; Bos et al., 2012). Oxytocin is thought to
increase socially oriented or approach-related behaviors
via increased positive emotions, but facilitation of nega-
tive emotions has repeatedly been found as well (for an
overview see Kemp and Guastella, 2011). Emotional infor-
mation from faces, and especially the eye region, is gen-
erally recognized better after oxytocin administration
(e.g. Domes et al., 2007; Marsh et al., 2010; Schulze
et al., 2011; for a review see van Ijzendoorn and Baker-
mans-Kranenburg, 2012). This might be induced by
increases in attention towards the eye region (e.g. Guas-
tella et al., 2008a,b; Gamer et al., 2010; Domes et al.,
2012a), although several studies found no effects of oxy-
tocin on gaze behavior (Domes et al., 2010; Lischke et al.,
2012b), or even showed that emotion recognition can be
affected without changes in gaze behavior (Lischke et al.,
2012a). Modulation of amygdala activity by oxytocin may
be responsible for the changes in attentional processes,
emotion recognition and behavior (Meyer-Lindenberg
et al., 2011; Bos et al., 2012; Striepens et al., 2012).
Most behavioral effects of oxytocin are found on more
conceptual and elaborate processing levels, but recent
evidence shows that even early automatic attentional or
recognition processes may be affected by oxytocin (Guas-
tella et al., 2009; Schulze et al., 2011; Domes et al.,
2012a; Ellenbogen et al., 2012a,b). As recognition of emo-
tional expressions in faces, and attention to the eye region
seem enhanced by oxytocin, we sought to investigate
whether oxytocin administration would lead to increased
orienting of attention in response to eye gazes of emo-
tional faces. This might indicate amplified information
processing during socially salient encounters, as emotional
gazes may indicate safety or threat in a specific location.
Changes in such early attentional processing due to
oxytocin may underlie changes in cognitive and
emotional processing at more elaborate and behavioral
levels.
In the current study we examined performance on an
emotional gaze cueing task after oxytocin compared to
placebo. When a face that gazes toward the periphery is
presented in the centre of a computer screen, spatial
attention in the observer is quickly and automatically
oriented toward the gazed at side of the screen. This will
speed up responding when a target is presented at the
gazed location (valid cue) and slow down responding when
a target is presented on the other side (invalid cue),
leading to a cueing effect (i.e. a positive difference
between reaction times to invalid minus valid cues). We
hypothesized that intranasal oxytocin administration
would enhance orientation of spatial attention in response
to moving eye gazes when these are expressed in emo-
tional versus neutral faces. With regard to the pro-social
theory on oxytocin, we might expect this enhancement
specifically on cueing scores for positive (happy) faces, but
social salience theory would predict enhanced cueing
scores for both positive and negative (fearful) faces. We
hope to shed more light on this distinction. Because stress
reducing effects of OXT have been found before (Bos et al.,
2012), we also investigated whether changes in physiolo-
gical or psychological stress levels would mediate the
effects of oxytocin.2. Methods
2.1. Participants
Twenty healthy young men aged 18—27 years (M = 21, SD = 3)
from Leiden University participated. For the purpose of
homogeneity only males were included, as gender differ-
ences in oxytocin effects have been found before (Domes
et al., 2010; Lischke et al., 2012b). All men were medication
and drug free, reported no (history of) major physical,
neurological or psychiatric illness. Participants were
instructed to use no alcohol or caffeine on the day of the
experiment, and not to eat or drink 2 h in advance, except
water. Participants gave written informed consent and the
study was approved by the local review board. One partici-
pant dropped-out after the first session due to illness, and
was hence not included in the analyses.
2.2. Procedure
A placebo-controlled double-blind randomized crossover
design was employed. Test sessions were separated by 5—7
days and started between 8:30 am and 6:00 pm. The two
sessions started around the same time per participant, to
control for circadian rhythms in cortisol. Each participant
once received 24 international units (IU) of oxytocin via a
nasal spray (3 puffs per nostril with 4 IUs1 of Syntocinon,
Sigma Tau), and once 6 puffs from an identical looking
placebo nasal spray containing all ingredients except oxyto-
cin. No undesired side effects were observed. Trait anxiety
(STAI; Spielberger et al., 1983, max score 80) and depression
(BDI-II; Beck et al., 1996, max score 63) measures were
collected on the first session. The emotional gaze cue task
was performed 35 min after treatment. To control for non-
specific mood and anxiety effects, STAI-state was measured
at 3 moments during the experiment; before treatment and
30 and 60 min after treatment. Also, blood pressure and
heart rate measures, as well as saliva samples to measure
cortisol levels were taken at these times as physiological
measures for stress.
2.3. Emotional gaze cueing task
The emotional gaze cueing task used eight different oval
gray-scaled cut-outs from photos of facial expressions (four
males and four females) from Ekman and Friesen’s Pictures of
Facial Affect (Ekman and Friesen, 1976), and directly gazing
faces from the Karolinska Directed Emotional Faces (Lundq-
vist et al., 1998). After presentation of a fixation cross for
750 ms, directly gazing happy, neutral, or fearful faces were
presented for 100 ms with the fixation cross superimposed on
it. These static faces appeared for another 200 ms, depicting
the same person with the same expression, with eyes looking
toward the left or right side. Participants were instructed to
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predict target occurrence. Then a triangle-shaped target
appeared 98 to the left or right side of the fixation cross
and the participants had to indicate as fast as possible
whether the triangle pointed up or downwards with their
dominant index finger on a keyboard. Response times (RT)
were recorded after onset of the target. Upon recording of RT
or after 1500 ms, the screen would go blank for 2—3 s before a
next trial began. After 6 practice trials, 96 trials with equal
numbers of neutral, happy and fearful trials, valid and invalid
cueing trials, and left and right target presentations were
presented, fully counterbalanced and randomized. The EGCT
lasted approximately 7 min.
3. Data reduction and analyses
To measure the effects of oxytocin on stress levels, we
performed a Multivariate Repeated Measures (RM-) ANOVA
with time (before, 30 min and 60 min after treatment) and
treatment (oxytocin versus placebo) as within-subject vari-
ables and cortisol levels, heart rate, systolic blood pressure
and STAI-state anxiety scores as dependent variables.
Before analyses of the EGCT, error trials were removed,
after which RTs below 200 ms were removed as premature
response, and RTs of 3 SDs above the mean were removed as
slow outliers (first session 1: 750 ms; second session: 692 ms).
One participant had 23% of scores removed during his placebo
session due to errors or outliers. He was hence removed from
further analyses, leaving 18 participants for analyses. There
were no differences between the oxytocin and placebo ses-
sion in errors ðmean oxytocin ¼ 2:2 ð2:1Þ; mean placebo ¼
2:1 ð1:8Þ; Fð1; 17Þ ¼ :147; p ¼ :71; h2p ¼ :009 premature res-
ponses ðmean oxytocin ¼ 0 ð0Þ; mean placebo ¼ 0:05 ð:24Þ;
Fð1; 17Þ ¼ 1:0; p ¼ :33; h2p ¼ :056Þ or slow outliers ðmean
oxytocin¼1:3 ð1:7Þ; mean placebo¼2:4 ð3:1Þ; Fð1; 17Þ ¼ 2:1;
p ¼ :16; h2p ¼ :11Þ.
Cueing scores were then calculated by subtracting mean
RTs to valid cueing trials from mean RTs to invalid cueing trials,
separately for neutral, happy and fearful gaze cue conditions.
Higher cueing scores indicate stronger attentional cueing for
that face type. A RM-ANOVA was performed with emotion
(neutral, happy, fearful) and treatment (oxytocin, placebo)
as within-subject variables, and treatment order as between-
subject variable. Post hoc ANOVAs per emotion were per-
formed. Subsequently, trait anxiety and depression scores
were added to the RM-ANOVA as covariates.Table 1 Means (SD) for all four stress measures over time in the
Stress measures Treatment 
Cortisol (nmol/L) Placebo 
Oxytocin 
Heart rate (bpm) Placebo 
Oxytocin 
Systolic blood pressure (mmHg) Placebo 
Oxytocin 
STAI-state Placebo 
Oxytocin All analyses were performed in SPSS 19, alpha was set at
0.05 (two-tailed), and as estimates of effect size we report
partial eta-squared ðh2pÞ.
4. Results
STAI-trait anxiety scores ranged between 30 and 51
(M = 35.8, SD = 5.4) and BDI depression scores ranged
between 0 and 17 (M = 6.8, SD = 5.2). Cortisol levels
(nmol/L), heart rate, systolic blood pressure and STAI-state
anxiety scores were entered in a Multivariate RM-ANOVA to
test whether oxytocin reduced stress levels at 30 and 60 min
after administration. While stress levels decreased over time
ðFð8; 52Þ ¼ 7:9; p < :001; h2p ¼ :55Þ, no interaction between
treatment and time was found ðFð8; 52Þ ¼ 1:6; p ¼ :15;
h2p ¼ :20Þ, see Table 1. When average starting time was
included as a covariate to account for circadian rhythms,
the effect of oxytocin did not differ (treatment by time
interaction: ðFð8; 48Þ ¼ 0:67; p ¼ :72; h2p ¼ :10Þ. No stress
reducing effects of oxytocin were shown, and stress level
was hence not included as a mediator in subsequent
analyses.
Cueing scores (RT invalid minus RT valid) per emotion and
treatment are shown in Fig. 1. A RM-ANOVA with emotion
(neutral, happy, fearful) and treatment (oxytocin, placebo)
as within-subject variables and treatment order as between-
subject variable showed that there was no main effect of
emotion on cueing scores ðFð2; 32Þ ¼ 1:93; p ¼ :16;
h2p ¼ :11Þ. Also within the placebo session, no main effect
of emotion was found ðFð2; 32Þ ¼ 2:39; p ¼ :11; h2p ¼ :13Þ.
There was a main effect of treatment ðFð1; 16Þ ¼ 5:37;
p ¼ :034; h2p ¼ :25Þ, and the crucial emotion by treatment
interaction was also significant ðFð2; 32Þ ¼ 3:35; p ¼ :048;
h2p ¼ :17Þ. Post hoc ANOVAs showed that cueing scores were
higher after oxytocin treatment versus placebo for the happy
and fearful faces ðresp: ðFð1; 16Þ ¼ 6:63; p ¼ :020; h2p ¼
:29Þ and ðFð1; 16Þ ¼ 5:07; p ¼ :039; h2p ¼ :24ÞÞ, but not for
the neutral faces ðFð1; 16Þ ¼ :52; p ¼ :48; h2p ¼ :032Þ, indi-
cating increased gaze cued orienting of attention for emo-
tional faces after oxytocin administration compared to
placebo.
No effects of treatment order were found in any of the
analyses (all p’s > .13). There were furthermore no signifi-
cant interactions between treatment, emotion and STAI-trait
anxiety (all p’s > .068) or BDI depression scores (all p’s > .65)
when these were entered as covariates. placebo and oxytocin condition.
Before
treatment
30 min after
treatment
60 min after
treatment
14.5 (1.8) 11.0 (1.7) 8.3 (1.1)
14.4 (2.7) 11.3 (1.9) 9.2 (1.6)
65.9 (3.5) 60.4 (2.2) 56.7 (2.2)
60.8 (2.9) 57.7 (2.5) 55.2 (2.3)
128 (3.1) 118 (2.4) 116 (2.6)
126 (2.5) 121 (2.3) 122 (2.5)
30.1 (1.3) 28.6 (1.8) 29.8 (1.6)
30.0 (1.2) 27.6 (1.3) 27.9 (1.0)
Figure 1 Gaze cueing scores (M, SEM) per emotion and treatment (N = 18).
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In the current study we show that oxytocin administration in
healthy young men leads to an increase in the orienting of
attention to gaze cues when these are presented in happy
and fearful faces but not in neutral faces. These results are in
line with the views that oxytocin increases social salience (for
discussions see Bartz et al., 2011; Kemp and Guastella, 2011),
and that it enhances the processing of (emotional) informa-
tion already at an early stage (see also Schulze et al., 2011;
Domes et al., 2012a; Ellenbogen et al., 2012a,b).
Oxytocin thus seems to induce automatic responding to
perception of socially relevant information from the eye
region, either by increased perception of emotional gaze
cues or by stronger automatic orienting in response to this
information. This may be useful in detecting safety and
threat signals, as to avert potential stress from these signals
or to decide to approach or avoid an object or location. This
finding suggests a relation between oxytocin and an impor-
tant cognitive-emotional process that is of great importance
in social conduct and theory of mind (Emery, 2000).
While we studied early automatic orienting of attention to
information from the eyes, increased attention to the human
eye region after oxytocin administration has been shown
before, although with mixed results. That is, Guastella
et al. (2008a,b) found increased gaze behavior to neutral
faces and Gamer et al. (2010) to neutral, happy and fearful
expressions. However, while Domes et al. (2012b) also found
increased gaze behavior to neutral and happy expressions,
they found a decrease in eye gaze to angry expressions, and
Domes et al. (2010), Lischke et al. (2012b) and Lischke et al.
(2012a) found no effects of oxytocin on gaze behavior at all.
In another study though, Domes et al. (2012a) found an
increase in covert attention to happy expressions, but not
to overt gaze behavior, indicating that early automatic
attentional orienting is a different process than the (reflex-
ive) shifting of eye gazes towards a location. In the current
study, we now show that oxytocin guides spatial attention by
cues from the eyes, but only for emotional facial expressions.
How these findings relate to changes in more overt gaze
behavior and e.g. emotion recognition due to oxytocin should
to topic of future research.
We thus found both enhanced orienting of attention to
gaze cues from positive (happy) and negative (fearful) faces,
indicating a general emotional facilitation of spatial atten-
tion irrespective of valence. This contradicts views of pro-
social or fear reducing effects of oxytocin, which are found atmore elaborate processing levels, and recently on early
attentional processes as well (Domes et al., 2012a; Ellenbo-
gen et al., 2012b). That is, Domes et al. (2012a) only found
enhanced attentional bias for positive (happy) faces but not
to negative (angry) faces, and Ellenbogen et al. (2012b)
showed a reduced attentional bias for negative (sad/angry)
faces after oxytocin compared to placebo. Both of those
findings are more in line with pro-social effects of oxytocin.
Several reasons may account for these seemingly contra-
dictory findings to our results. While both of those studies
used exogenous cueing tasks, we studied automatic atten-
tional orienting to centrally presented cues, indicating a
possible differential processing of centrally presented emo-
tional cues after oxytocin administration than peripherally
presented cues. In a later study by Ellenbogen et al. (2012a),
in which they studied the inhibition of centrally presented
emotional faces, they found a reduced inhibition of sad facial
expressions (although only in a group with depressive symp-
toms, and not for happy and angry expressions). This reduced
inhibition is more analogous to the reduced ability to sup-
press automatic responding to centrally presented emotional
gaze cues in the current study. Furthermore, the current
study used averting gazes instead of directly gazing faces,
which may change the perception of the emotional content of
the expression (Adams et al., 2003). Moreover, these previous
studies used sad and/or angry facial expressions, while we
used fear as a negative emotion, and contrasted this with
happy faces. While fearful and happy expressions may indi-
cate signals for safety (approach) and danger (avoid), angry
faces may elicit either approach or avoidance behavior (Put-
man et al., 2004), while sad faces may elicit empathic
responses. As different types of negative expressions may
induce different action tendencies, oxytocin can have
expression-specific effects. In conclusion, the early atten-
tional processing of emotional faces after oxytocin adminis-
tration may be expression-specific, and the (spatial) context
and presentation of facial and eye cues can significantly
affect outcomes. Future research should carefully compare
the diverse attentional processes and emotions that are
either suppressed or enhanced by oxytocin, both at very
early automatic, and relatively later, more elaborate proces-
sing levels.
We found no moderation of the effect by trait anxiety or
depressed mood, suggesting the effect may be independent
of potential existing emotional biases. However, we tested a
relatively small and non-anxious group that showed no emo-
tional bias in the cueing scores to start with. Previously,
enhanced attentional orienting to fearful compared to happy
Oxytocin and emotional gaze cues 1801faces in healthy subjects under placebo condition has been
shown with a comparable gaze cue paradigm (Putman et al.,
2010). The fact that we found no emotional bias under
placebo may be due to strict exclusion criteria for psycho-
logical problems, reflecting a healthy population without any
emotional biases. However, as oxytocin may differentially
affect early attentional processes dependent on pre-existing
biases (Ellenbogen et al., 2012b), it would be important to
test whether oxytocin also specifically enhances emotional
biases in the orientation of attention in groups with (sub)-
clinical levels of anxiety or depression as well, which are
known to have heightened attentional biases to negative
information (Frewen et al., 2008).
In sum, we add new findings to the recently established
early attentional effects of oxytocin, in specific an enhance-
ment of orienting in response to emotional gaze cues. These
effects are found in a healthy male population, and should be
replicated in (sub)clinical populations and in females, as
gender difference in the response to oxytocin have been
found before (Domes et al., 2010; Lischke et al., 2012b).
Because the effects of oxytocin on early attentional proces-
sing in this and in earlier studies are relatively small, replica-
tion is needed, and the significance of these findings for
higher level functioning, e.g. emotion recognition, approach
behavior and social memory, should be topic of future
research.
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